Skip to content

Source filing unavailable

Q4 2012 · —
Revenue$214.43M+5.4% vs Q4 2011+2.1% vs Q3 2012
Net Income$12.79M+180.4% vs Q4 2011−3.2% vs Q3 2012
EPS Diluted$0.46+187.5% vs Q4 2011±0.0% vs Q3 2012
Gross Profit$132,502,000+9.7%
Operating Incomederived$18,558,000+139.5%
Operating Cash Flowderived-$3,403,000N/M
Free Cash Flowderived-$28,075,000N/M
Margins · derived
Gross margin61.8%+2.4 pt vs Q4 2011
Operating margin8.7%+4.8 pt vs Q4 2011
Net margin6.0%+3.7 pt vs Q4 2011

What the release said

No earnings release is on file for this quarter. Its figures came with the 10-Q.

Same quarter

MetricQ4 2012Q4 2011Q4 2010Q4 2009derived from reported figures
Revenue$214.43M$203.52M$194.13M—
Net Income$12.79M$4.56M$18.81M—
EPS Diluted$0.46$0.16$0.63—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Integra Lifesciences Holdings Corp · CIK 917520 · Engraved from SEC EDGAR